Published in Best Pract Res Clin Endocrinol Metab on November 22, 2013
Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev (2015) 1.03
Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development. World J Gastroenterol (2014) 0.94
A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer. Oncotarget (2015) 0.85
Review: adiponectin in retinopathy. Biochim Biophys Acta (2016) 0.78
Obesity and cancer: the role of adipose tissue and adipo-cytokines-induced chronic inflammation. J Cancer (2016) 0.77
Linking adiponectin and autophagy in the regulation of breast cancer metastasis. J Mol Med (Berl) (2014) 0.76
Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients. Med Sci Monit (2017) 0.75
Association of leptin, visfatin, apelin, resistin and adiponectin with clear cell renal cell carcinoma. Oncol Lett (2016) 0.75
Adiponectin confers protection from acute colitis and restricts a B cell immune response. J Biol Chem (2017) 0.75
Adipocytokines in renal transplant recipients. Clin Kidney J (2016) 0.75
Differential Associations between CDH13 Genotypes, Adiponectin Levels, and Circulating Levels of Cellular Adhesive Molecules. Mediators Inflamm (2015) 0.75
ADIPOQ rs266729 G/C gene polymorphism and plasmatic adipocytokines connect metabolic syndrome to colorectal cancer. J Cancer (2017) 0.75
Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort. Sci Rep (2017) 0.75
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Defining the role of mTOR in cancer. Cancer Cell (2007) 21.63
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med (2001) 16.51
Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer (2008) 15.20
AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab (2005) 13.91
Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature (2006) 12.13
Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer (2008) 11.50
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 11.19
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell (2002) 10.34
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 9.79
A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem (1995) 9.72
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev (2003) 9.58
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest (2006) 9.49
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol (2008) 8.43
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer (2009) 8.43
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell (2010) 7.59
Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol (2011) 7.07
AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem (1996) 6.93
AMPK in Health and Disease. Physiol Rev (2009) 6.38
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A (2001) 6.20
Adipose tissue remodeling and obesity. J Clin Invest (2011) 6.12
PI3K/Akt signalling pathway and cancer. Cancer Treat Rev (2004) 5.46
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem (2003) 5.40
cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun (1996) 5.40
Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med (2010) 4.96
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab (2002) 4.64
Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem (2002) 4.60
Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem (2003) 4.38
Sphingosine 1-phosphate and cancer. Nat Rev Cancer (2010) 3.95
T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. Proc Natl Acad Sci U S A (2004) 3.90
APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol (2006) 3.55
Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes (2006) 3.14
Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem (2004) 3.01
The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr Biol (1998) 3.00
Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol (2011) 2.97
Wnt signaling in cancer. Cold Spring Harb Perspect Biol (2012) 2.75
Adiponectin: mechanistic insights and clinical implications. Diabetologia (2012) 2.71
Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev (2013) 2.65
Adiponectin and inflammation: consensus and controversy. J Allergy Clin Immunol (2007) 2.63
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proc Natl Acad Sci U S A (2009) 2.55
The tuberous sclerosis complex. Ann N Y Acad Sci (2010) 2.51
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: possible role of obesity-related stimuli. Clin Cancer Res (2006) 2.41
Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem (2003) 2.29
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol (2010) 2.11
Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res (2006) 2.03
RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res (2005) 2.01
LKB1; linking cell structure and tumor suppression. Oncogene (2008) 1.96
Plasma adiponectin complexes have distinct biochemical characteristics. Endocrinology (2008) 1.94
Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metab (2013) 1.85
Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res (2007) 1.81
The role of adiponectin in cancer: a review of current evidence. Endocr Rev (2012) 1.78
Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res (2006) 1.75
Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol (2008) 1.73
T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest (2010) 1.66
Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice. Gut (2012) 1.65
Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology (2004) 1.65
Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev (2011) 1.65
Systemic fate of the adipocyte-derived factor adiponectin. Diabetes (2009) 1.65
T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region. Neuron (1991) 1.65
Plasma adiponectin and gastric cancer. Clin Cancer Res (2005) 1.62
Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res (2005) 1.61
Adiponectin, driver or passenger on the road to insulin sensitivity? Mol Metab (2013) 1.58
Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res (2009) 1.58
Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms. Exp Diabetes Res (2012) 1.55
T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res (2008) 1.54
Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation. Mol Endocrinol (2010) 1.44
APPL1: role in adiponectin signaling and beyond. Am J Physiol Endocrinol Metab (2008) 1.41
Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. Hum Mol Genet (2010) 1.38
Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res (2013) 1.37
Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways. J Biol Chem (2012) 1.37
Molecular mechanisms of leptin and adiponectin in breast cancer. Eur J Cancer (2011) 1.36
Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem Biophys Res Commun (2005) 1.28
Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res (2010) 1.26
Cadherin 13 in cancer. Genes Chromosomes Cancer (2010) 1.26
Glucose transporters in cancer metabolism. Curr Opin Oncol (2012) 1.25
The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry (2008) 1.23
Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology (2010) 1.23
Selective inhibition of fatty acid synthase for lung cancer treatment. Clin Cancer Res (2007) 1.22
Glycosyl phosphatidylinositol--anchored T-cadherin mediates calcium-dependent, homophilic cell adhesion. J Cell Biol (1992) 1.19
Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf) (2010) 1.18
Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control (2008) 1.15
CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat (2011) 1.14
Obesity in cancer survival. Annu Rev Nutr (2012) 1.13
Adiponectin deficiency limits tumor vascularization in the MMTV-PyV-mT mouse model of mammary cancer. Clin Cancer Res (2009) 1.11
Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett (2006) 1.10
Design and development of a peptide-based adiponectin receptor agonist for cancer treatment. BMC Biotechnol (2011) 1.09
Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors. Biol Chem (2010) 1.08
Adiponectin--it's all about the modifications. Int J Biochem Cell Biol (2010) 1.06
T-cadherin is essential for adiponectin-mediated revascularization. J Biol Chem (2013) 1.05
Leptin and gastro-intestinal malignancies. Obes Rev (2010) 1.04
Serum adiponectin level and different kinds of cancer: a review of recent evidence. ISRN Oncol (2012) 1.01
Adipocytes: impact on tumor growth and potential sites for therapeutic intervention. Pharmacol Ther (2013) 1.00
Adiponectin, type 2 diabetes and the metabolic syndrome: lessons from human genetic studies. Expert Rev Mol Med (2006) 0.97
Control of cell growth and survival by enzymes of the fatty acid synthesis pathway in HCT-116 colon cancer cells. Clin Cancer Res (2008) 0.96
Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int J Cancer (2011) 0.95
Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies. Oncology (2008) 0.94
The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem Biophys Res Commun (2006) 0.93
Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Carcinogenesis (2008) 0.92
The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis. Biochimie (2012) 0.88
Sialic acid modification of adiponectin is not required for multimerization or secretion but determines half-life in circulation. Mol Endocrinol (2009) 0.87